DENVER, Aug. 7 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.'s (OTC:GLOB) (BULLETIN BOARD: GLOB) CEO, Dr. Mick Ruxin, today announced that Global Med's Wyndgate Technologies(R) division and Florida's Blood Centers (FBC), one of the nation's leading independent blood banks, have signed an agreement for the Company's Vein-to-Vein(R) software, SafeTrace(R) donor management, SafeTrace Tx(R) advanced transfusion management, and ElDorado(TM) Donor Doc(TM), Wyndgate's newest software offering. With a value of several million dollars over a five-year period, Florida's Blood Centers will be the largest user of Wyndgate's Vein-to-Vein software on the East Coast. Specific terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Anne K. Chinoda, President and Chief Executive Officer of Florida's Blood Centers, stated, "We evaluated many of the blood bank systems on the market and chose SafeTrace and SafeTrace Tx for a number of reasons. Namely, the system provides us with the ability to streamline our business processes, providing added functionality and reporting features. Additionally, we feel we have the assurance of a successful implementation, including training and education, in a timeframe that meets our needs." Dr. Ruxin, Chairman and CEO of Global Med Technologies, Inc., commented, "We are particularly gratified by this vote of confidence from FBC in our Vein-to-Vein software system. We believe that this multi-year, multi-million dollar contract presages the future direction of Global Med Technologies." Florida's Blood Centers, the largest blood center in Florida, is the sole supplier of blood and blood products to 72 healthcare facilities in a 21- county area. It was searching for a software solution that could replace the existing system that supported both donor collections and transfusion. FBC found this solution with Wyndgate's Vein-to-Vein blood management software. With nearly 350,000 units of blood and blood products labeled annually, SafeTrace will allow FBC to streamline many of its critical processes and help assure the safety of the blood products provided to area hospitals. SafeTrace Tx, a powerful transfusion service management information system, is designed to fully support FBC's enterprise-wide centralized transfusion services (CTS) management, including advanced functionality such as electronic and remote crossmatch, automated patient special needs and antigen/antibody screens. With the purchase of ElDorado Donor Doc, Florida's Blood Centers becomes the first to implement this electronic health history questionnaire and physical exam tracking system. Recently cleared by the FDA for sale in the U.S., Donor Doc will assist FBC with screening donors and capturing relevant medical information. This next-generation software, the first module of Wyndgate's planned ElDorado suite of blood management products, has been designed to automate screening processes to provide data quality assurance and support regulatory compliance. The system is intended to interface with SafeTrace and will allow FBC to easily access donation information. Thomas F. Marcinek, President and Chief Operating Officer of Wyndgate Technologies, commented, "Over the past three years, Wyndgate has had the opportunity to work with Florida's Blood Centers as they thoroughly researched an appropriate software solution for their complex organization's blood management system. We have been very impressed with the professionalism shown by the management and staff of Florida's Blood Centers. Furthermore, we are very pleased with the quality of our business relationship and the mutual respect we have developed for one another." Mr. Marcinek continued, "FBC has a rich history of being the forerunner of new developments in the blood industry. Wyndgate is particularly proud that FBC has continued this legacy by being the first to purchase our newest software product, ElDorado Donor Doc. We look forward to meeting their needs now and long into the future." About Florida's Blood Centers Florida's Blood Centers was established in 1942, shortly after the start of World War II. During its 65 years, FBC has consistently provided the communities it serves with a safe and adequate blood supply. In addition to supplying blood and blood products, FBC offers HLA tissue matching, bone- marrow donor registration and a full-service tissue and eye bank. It was one of the first blood centers in the country to implement new capabilities and services such as frozen blood storage, a national clearinghouse system for exchanging blood, community branches and bloodmobile collection. FBC's management is actively involved in shaping the future safety of the world's blood supply. Anne Chinoda, President and CEO, is part of a global task force of international leaders representing the U.S., Europe, Southeast Asia, Australia, Central and South America and Canada working to bring global convergence in blood and medical research. For more information, visit http://www.floridasbloodcenters.org/. About Global Med Technologies, Inc. Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, peoplemed.com, and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGODATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D., Global Med Technologies, Inc., +1-303-238-2000; investors, Paul Holm, H.L. Lanzet, +1-212-888-4570, , for Global Med Technologies, Inc. Web site: http://www.globalmedtech.com/ http://www.floridasbloodcenters.org/ http://peoplemed.com/ http://www.wyndgate.com/

Copyright